Corrections, Department of; hepatitis C antiviral medication. (HB1651)

Introduced By

Del. Dawn Adams (D-Richmond) with support from co-patrons Del. Patrick Hope (D-Arlington), Del. Sam Rasoul (D-Roanoke), and Sen. Joe Morrissey (D-Richmond)


Passed Committee
Passed House
Passed Senate
Signed by Governor
Became Law


Department of Corrections; hepatitis C antiviral medication. Directs the Department of Corrections to issue a Request for Proposals to pharmaceutical manufacturers for the purchase of an unrestricted five-year supply of hepatitis C antiviral medication and any necessary ancillary services at an annual fixed rate. The bill requires the Department to report to the Governor and the General Assembly by November 30, 2020, and by November 30 during each year of the contract, regarding the status of the contract, whether the contract has lowered the Department's hepatitis C treatment costs, and inmate health outcomes resulting from the contract. Read the Bill »


Bill Has Failed


01/16/2020Presented and ordered printed 20105572D
01/16/2020Referred to Committee on Public Safety
01/22/2020Assigned PS sub: Public Safety
01/27/2020Impact statement from DPB (HB1651)
01/30/2020Subcommittee recommends reporting (6-Y 2-N)
01/30/2020Subcommittee recommends referring to Committee on Appropriations
01/31/2020Reported from Public Safety (21-Y 1-N) (see vote tally)
01/31/2020Referred to Committee on Appropriations
02/11/2020Left in Appropriations